RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2017, it operated 11 hospitals and 5,370 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
Phone+49-9-771650
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees16,829
OptionableNot Optionable
Rhoen Klinikum (ETR:RHK) Frequently Asked Questions
What is Rhoen Klinikum's stock symbol?
Rhoen Klinikum trades on the ETR under the ticker symbol "RHK."
What price target have analysts set for RHK?
7 Wall Street analysts have issued 1 year price objectives for Rhoen Klinikum's shares. Their predictions range from €19.00 to €25.50. On average, they expect Rhoen Klinikum's share price to reach €21.71 in the next year. This suggests that the stock has a possible downside of 2.5%. View Analyst Price Targets for Rhoen Klinikum.
What is the consensus analysts' recommendation for Rhoen Klinikum?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rhoen Klinikum in the last year. There are currently 4 sell ratings and 3 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Rhoen Klinikum.
Has Rhoen Klinikum been receiving favorable news coverage?
Media coverage about RHK stock has been trending very positive on Wednesday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rhoen Klinikum earned a coverage optimism score of 3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are some of Rhoen Klinikum's key competitors?
Some companies that are related to Rhoen Klinikum include Agility Health (AHI), Amadeus It Group (AMS), Assure (IOM), Blvd Centers (CXV), Brain Resource (BRC), Cambian Group (CMBN), CareTech (CTH), CENTRIC HEALTH (CHH), CHAMPION PAIN C/SH SH (CPAI), Eviana Health (EHC), Fresenius Medical Care AG & Co. KGaA (FME), Georgia Healthcare Group (GHG), Greencross (GXL), Healius (HLS) and Konekt (KKT).
Who are Rhoen Klinikum's key executives?
Rhoen Klinikum's management team includes the folowing people:
- Mr. Stephan Holzinger, Chairman of Board of Management & CEO
- Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management
- Dr. Gunther Weiß, COO & Member of Management Board (Age 53)
- Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)
- Julian Schmitt, Head of Investor Relation
What is Rhoen Klinikum's stock price today?
One share of RHK stock can currently be purchased for approximately €22.28.
What is Rhoen Klinikum's official website?
How can I contact Rhoen Klinikum?
Rhoen Klinikum's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.
MarketBeat Community Rating for Rhoen Klinikum (ETR RHK)
MarketBeat's community ratings are surveys of what our community members think about Rhoen Klinikum and other stocks. Vote "Outperform" if you believe RHK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHK will underperform the S&P 500 over the long term. You may vote once every thirty days.
